Phase II study of cabazitaxel with or without abiraterone acetate and prednisone in patients with metastatic castrate resistant prostate cancer after prior docetaxel and abiraterone acetate
| Autor: | Kessler, E.R., Gao, D., Flaig, T.W., Breaker, K., Wold, M., Wacker, M., Lam, E.T. |
|---|---|
| Zdroj: | In Annals of Oncology March 2017 28(3):668-668 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|